Perrot, Ivan
Michaud, Henri-Alexandre
Giraudon-Paoli, Marc
Augier, Séverine
Docquier, Aurélie
Gros, Laurent
Courtois, Rachel
Déjou, Cécile
Jecko, Diana
Becquart, Ondine
Rispaud-Blanc, Hélène
Gauthier, Laurent
Rossi, Benjamin
Chanteux, Stéphanie
Gourdin, Nicolas
Amigues, Beatrice
Roussel, Alain
Bensussan, Armand
Eliaou, Jean-François
Bastid, Jérémy
Romagné, François
Morel, Yannis
Narni-Mancinelli, Emilie
Vivier, Eric
Paturel, Carine
Bonnefoy, Nathalie
Funding for this research was provided by:
European Community’s Seventh Framework Program
French Infrastructure for Integrated Structural Biology
Agence Nationale pour la Recherche
Cancéropole Grand Sud-Ouest
French National Research Agency
FRM
Fondation pour la recherche Nuovo Soldati
European Research Council (694502)
Agence Nationale de la Recherche
Ligue Nationale contre le Cancer
MSDAvenir
Innate Pharma
ANR
This article is maintained by: Elsevier
Article Title: Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies
Journal Title: Cell Reports
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.celrep.2019.04.091
Content Type: article
Copyright: © 2019 The Author(s).